BME:CCEP Statistics

Total Valuation

BME:CCEP has a market cap or net worth of EUR 35.29 billion. The enterprise value is 45.51 billion.

Market Cap	35.29B
Enterprise Value	45.51B

Important Dates

The next estimated earnings date is Wednesday, August 6, 2025.

Earnings Date	Aug 6, 2025
Ex-Dividend Date	Nov 15, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.44%
Shares Change (QoQ)	+0.43%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	213.47M

Valuation Ratios

The trailing PE ratio is 24.88.

PE Ratio	24.88
Forward PE	n/a
PS Ratio	1.73
PB Ratio	3.93
P/TBV Ratio	n/a
P/FCF Ratio	15.54
P/OCF Ratio	11.53
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.48, with an EV/FCF ratio of 20.05.

EV / Earnings	32.10
EV / Sales	2.23
EV / EBITDA	13.48
EV / EBIT	17.65
EV / FCF	20.05

Financial Position

The company has a current ratio of 0.81, with a Debt / Equity ratio of 1.27.

Current Ratio	0.81
Quick Ratio	0.57
Debt / Equity	1.27
Debt / EBITDA	3.39
Debt / FCF	5.04
Interest Coverage	9.81

Financial Efficiency

Return on equity (ROE) is 17.03% and return on invested capital (ROIC) is 8.07%.

Return on Equity (ROE)	17.03%
Return on Assets (ROA)	5.34%
Return on Invested Capital (ROIC)	8.07%
Return on Capital Employed (ROCE)	11.24%
Revenue Per Employee	498,488
Profits Per Employee	34,585
Employee Count	41,000
Asset Turnover	0.68
Inventory Turnover	8.88

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +21.02% in the last 52 weeks. The beta is 0.63, so BME:CCEP's price volatility has been lower than the market average.

Beta (5Y)	0.63
52-Week Price Change	+21.02%
50-Day Moving Average	79.00
200-Day Moving Average	73.75
Relative Strength Index (RSI)	51.31
Average Volume (20 Days)	1,072

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BME:CCEP had revenue of EUR 20.44 billion and earned 1.42 billion in profits. Earnings per share was 3.08.

Revenue	20.44B
Gross Profit	7.28B
Operating Income	2.58B
Pretax Income	1.94B
Net Income	1.42B
EBITDA	3.21B
EBIT	2.58B
Earnings Per Share (EPS)	3.08

Full Income Statement

Balance Sheet

The company has 1.71 billion in cash and 11.45 billion in debt, giving a net cash position of -9.73 billion.

Cash & Cash Equivalents	1.71B
Total Debt	11.45B
Net Cash	-9.73B
Net Cash Per Share	n/a
Equity (Book Value)	8.99B
Book Value Per Share	18.42
Working Capital	-1.51B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 3.06 billion and capital expenditures -791.00 million, giving a free cash flow of 2.27 billion.

Operating Cash Flow	3.06B
Capital Expenditures	-791.00M
Free Cash Flow	2.27B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 35.63%, with operating and profit margins of 12.62% and 6.94%.

Gross Margin	35.63%
Operating Margin	12.62%
Pretax Margin	9.47%
Profit Margin	6.94%
EBITDA Margin	15.72%
EBIT Margin	12.62%
FCF Margin	11.11%

Dividends & Yields

This stock pays an annual dividend of 2.00, which amounts to a dividend yield of 2.56%.

Dividend Per Share	2.00
Dividend Yield	2.56%
Dividend Growth (YoY)	10.81%
Years of Dividend Growth	4
Payout Ratio	64.17%
Buyback Yield	-0.44%
Shareholder Yield	2.12%
Earnings Yield	4.02%
FCF Yield	6.43%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BME:CCEP has an Altman Z-Score of 2.12. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.12
Piotroski F-Score	n/a